Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Reexamination Certificate
2007-11-06
2007-11-06
Achutamurthy, P. (Department: 1652)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
C435S183000, C435S004000, C435S006120, C435S024000, C514S789000, C536S023200, C536S023700, C536S023500
Reexamination Certificate
active
10047253
ABSTRACT:
The present invention is based on the discovery that a polypeptide containing the JAB subunit or the JAM domain has peptidase activity, e.g., isopeptidase activity. The present invention provides polypeptides and crystalline polypeptides containing the JAM domain and methods of using such polypeptides to screen for agents capable of affecting the peptidase activity of the polypeptides. The present invention also provides methods of using the JAM domain for rational drug design or identifying agents capable of affecting the peptidase activity of the JAM domain.
REFERENCES:
patent: 5976796 (1999-11-01), Szalay et al.
patent: 6165731 (2000-12-01), Deshaies et al.
patent: 1 130 029 (2001-09-01), None
patent: WO00/29436 (2000-05-01), None
patent: WO00/79267 (2000-12-01), None
Reiss et al. Specificity of binding of NH2-terminal residue of proteins to ubiquitin-protein ligase. Use of amino acid derivatives characterize specific binding sites. J Biol Chem. Feb. 25, 1988;263(6):2693-8.
Deshaies et al. SCF and Cullin/Ring H2-based ubiquitin ligases.Annu Rev Cell Dev Biol. 1999;15;435-67.
Bech-Otschir, et al., “COP9 Signalsome-specific Phosphorylation Target p53 to Degradation by the Ubiquitin System”,The EMBO J.20(7):1630-1639, (2001).
Ciechanover, et al., “Ubiquitin-mediated Proteolysis: Biological Regulation Via Destruction”,BioEssays22:442-451, (2000).
Eytan, et al., “Ubiquitin C-terminal Hydrolase Activity Associated with the 26 S Protease Complex”,J. of Bio. Chem.268(7):4668-4674, (Mar. 1993).
Löwe, et al., “Crystal Structure of the 20S Proteasome from the ArchaeonT. acidophilumat 3.4 Resolution”,Sci., 268:533-539, (Apr. 1995).
Lyapina, et al., “Promotion of NEDD8-CUL1 Conjugate Cleaveage by COP9 Signalsome”,Sci.292:1382-1385, (May 2001).
Tomoda, et al., “Degradation of the Cyclin-dependent-kinase Inhibitor p27kip1is instigated by Jab1”,Nat.398:160-165, (Mar. 1999).
Wei, et al., “The COP9 Complex is Conserved Between Plants and Mammals and is Related to the 26S Proteasome Regulatory Comples”,Cur. Bio.8(16):919-922, (1998).
Chamovitz and Segal, “JAB1/CSN5 and the COP9 Signalsome: A Complex Situation,”EMBO Reports, vol. 2, No. 2, 2001, pp. 96-101.
Ciechanover, Aaron et al., “Ubiquitin-Mediated Proteolysis: Biological Regulation Via Destruction,”BioEssays, vol. 22, 2000, pp. 442-451.
Glickman, Michael H. et al., “The Regulatory Particle of theSaccharomyces cerevisiaeProteasome,”Molecular and Cellular Biology, vol. 18, No. 6, Jun. 1998, pp. 3149-3162.
Groll, Michael et al., “The Eukaryotic 20S Proteaome: A Potential Target for Drug Development,” In DFG-Schwerpunkt, Strktur, Funktion and Regulation des 20S/26S Ubiquitin-Proteasomesystems Kolloquium, May 23-25, 2001, Program Abstract, accessed on Internet Jun. 20, 2002 at www.dfg-sp-ubiquitin.de.
Lyapina, Svetlana et al., “Promotion of NEDD8-CUL1 Conjugate Cleavage By CPO9 Signalosome,”Science, vol. 292, May 18, 2001, pp. 1382-1385.
Meiners, Silke et al., “Role of the Ubiquitin-Protease Pathway In Vascular Restenosis-Proteasome Inhibition As A New Therapeutic Approach,” In DFG-Schwerpunkt, Strktur, Funktion and Regulation des 20S/26S Ubiquitin-Proteasomesystems Kolloquium, May 23-25, 2001, Program Abstract, accessed on Internet Jun. 20, 2002 at www.dfg-sp-ubiquitin.de.
Wei, Ning et al., “The COP9 Complex Is Conserved Between Plants and Mammals and Is Related to the 26S Proteasome Regulatory Complex,”Current Biology, vol. 8, No. 16, Jul. 27, 1998, pp. 919-922 and S1 and S2.
Ambroggio Xavier
Aravind Lakshminarayanan
Cope Gregory
Deshaies Raymond
Koonin Eugene V.
Achutamurthy P.
California Institute of Technology
DLA Piper (US) LLP
National Institutes of Health
Pak Yong D.
LandOfFree
Regulation of target protein activity through modifier proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of target protein activity through modifier proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of target protein activity through modifier proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3866561